DRP1 haploinsufficiency attenuates cardiac ischemia/reperfusion injuries

Laura Bouche1, Rima Kamel1, Sophie Tamareille1

  • 1Institut MITOVASC, CNRS UMR 6015 INSERM U1083, Université d'Angers, Angers, France.

Plos One
|March 25, 2021
PubMed

Insights

Mice with reduced DRP1 protein (dynamin-related protein 1) showed smaller heart damage after ischemia/reperfusion injury. This protection was linked to increased autophagy, suggesting DRP1 deficiency may be beneficial.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Biology
  • Cellular Stress Response

Background:

  • Mitochondrial dynamics influence myocardial ischemia/reperfusion injuries (IRI).
  • Partial deficiency in the fusion protein OPA1 exacerbates IRI.
  • The role of the fission protein DRP1 in IRI is investigated.

Purpose of the Study:

  • To investigate the effect of DRP1 deficiency (Dnm1l+/- mice) on myocardial IRI.
  • To analyze cardiac and mitochondrial function in Dnm1l+/- mice under basal and I/R conditions.
  • To explore the underlying mechanisms of protection, including autophagy and mPTP opening.

Main Methods:

  • Baseline characterization of Dnm1l+/- mice using echocardiography, electron microscopy, and oxygraphy.
  • Exposure of Dnm1l+/- and wild type (WT) mice to myocardial ischemia/reperfusion (I/R).
  • Analysis of infarct size (AN/AAR), mitochondrial dynamics proteins, autophagy markers (LC3 II, P62), and mPTP opening sensitivity.

Main Results:

  • Dnm1l+/- mice exhibited 60% lower cardiac DRP1, increased mitochondrial area and lipid degradation, but preserved cardiac and mitochondrial function at baseline.
  • Following I/R, Dnm1l+/- mice showed significantly smaller infarct size compared to WT mice (34.6±3.1% vs. 44.5±3.3%).
  • Autophagic markers (LC3 II and P62) were significantly increased post-I/R in Dnm1l+/- mice only.

Conclusions:

  • Dnm1l deficiency, leading to increased mitochondrial fusion, confers protection against myocardial IRI.
  • This protection is associated with enhanced autophagy and occurs without compromising basal cardiac or mitochondrial function.
  • DRP1 haploinsufficiency represents a potential therapeutic target for mitigating heart injury during I/R events.

Related Concept Videos